Suppr超能文献

植物中异黄酮生物合成过程中的糖基化和甲基化 。 (原英文文本表述不完整,推测补充完整后的翻译)

Glycosylation and methylation in the biosynthesis of isoflavonoids in .

作者信息

Li Changfu, Zhang Yansheng

机构信息

Shanghai Key Laboratory of Bio-Energy Crops, School of Life Sciences, Shanghai University, Shanghai, China.

出版信息

Front Plant Sci. 2023 Dec 15;14:1330586. doi: 10.3389/fpls.2023.1330586. eCollection 2023.

Abstract

The pathway for forming isoflavonoid skeletal structure is primarily restricted to the Leguminosae family. Subsequent decorations on the compound backbone by tailoring enzymes would change their biological and medicinal properties. is a leguminous plant, and as a traditional Chinese medicine its roots have been ascribed a number of pharmacological activities. Glycosylation and methylation are the main modifying processes in isoflavonoid metabolism in roots, resulting in the accumulation of unique glycosylated and methylated end isoflavonoid compounds. For instance, daidzein 8--glucoside (i.e., puerarin) and puerarin derivatives are produced only by the genus. Puerarin has been established as a clinical drug for curing cardiovascular diseases. To better understand the characteristic isoflavonoid metabolism in , this review attempts to summarize the research progress made with understanding the main glycosylation and methylation of isoflavonoids in and their biosynthetic enzymes.

摘要

异黄酮骨架结构的形成途径主要局限于豆科植物。随后,修饰酶对化合物骨架的修饰会改变其生物学和药用特性。[植物名称]是一种豆科植物,作为传统中药,其根具有多种药理活性。糖基化和甲基化是[植物名称]根中异黄酮代谢的主要修饰过程,导致独特的糖基化和甲基化末端异黄酮化合物的积累。例如,大豆苷元8-O-葡萄糖苷(即葛根素)和葛根素衍生物仅由[植物名称]属产生。葛根素已被确立为治疗心血管疾病的临床药物。为了更好地了解[植物名称]中异黄酮代谢的特征,本综述试图总结在理解[植物名称]中异黄酮的主要糖基化和甲基化及其生物合成酶方面所取得的研究进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6232/10757850/2fb30924f0ea/fpls-14-1330586-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验